Clinical Trial Update: Azacitidine Combined With Venetoclax and ATRA in Newly Diagnosed AML [Phase 3]

View source ↗

Summary

Phase 3 trial investigating azacitidine combined with venetoclax and ATRA for newly diagnosed acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• ATRA (all-trans retinoic acid)
• AZACITIDINE (AZACITIDINE)
• Venetoclax (venetoclax)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: UNKNOWN